GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (FRA:SU6) » Definitions » YoY EPS Growth

Surmodics (FRA:SU6) YoY EPS Growth : 103.50% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Surmodics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Surmodics's YoY EPS Growth for the quarter that ended in Mar. 2024 was 103.50%.

Surmodics's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was €0.02.


Surmodics YoY EPS Growth Historical Data

The historical data trend for Surmodics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics YoY EPS Growth Chart

Surmodics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 271.48 -86.37 275.00 -876.47 94.80

Surmodics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -95.44 223.71 141.08 89.60 103.50

Surmodics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Surmodics's YoY EPS Growth for the fiscal year that ended in Sep. 2023 is calculated as:

YoY EPS Growth (A: Sep. 2023 )
=(Earnings per Share (Diluted) (A: Sep. 2023 )-Earnings per Share (Diluted) (A: Sep. 2022 ))/ | Earnings per Share (Diluted) (A: Sep. 2022 ) |
=(-0.103--1.98)/ | -1.98 |
=94.80 %

Surmodics's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EPS Growth (Q: Mar. 2024 )
=(Earnings per Share (Diluted) (Q: Mar. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(0.018--0.514)/ | -0.514 |
=103.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Surmodics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Surmodics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Surmodics (FRA:SU6) Business Description

Traded in Other Exchanges
Address
9924 West 74th Street, Eden Prairie, MN, USA, 55344
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Surmodics (FRA:SU6) Headlines

No Headlines